CADASIL: Treatment and Management Options

Anna Bersano, Gloria Bedini, Joshua Oskam, Caterina Mariotti, Franco Taroni, Silvia Baratta, Eugenio Agostino Parati

Research output: Contribution to journalReview articlepeer-review


CADASIL is a life-threatening and disabling disease. Despite the progress achieved so far, no therapies able to limit the disease progression have been found and only empiric treatments can be employed to relieve the main disease symptoms. Further in vivo studies as well as data aggregation and multi-centre controlled clinical trials are needed to confirm the emerging findings in order to identify evidence-based therapies for CADASIL.

Original languageEnglish
Article number31
JournalCurrent Treatment Options in Neurology
Issue number9
Publication statusPublished - Sept 1 2017


  • NOTCH3 gene
  • Pathogenesis
  • Therapy

ASJC Scopus subject areas

  • Clinical Neurology


Dive into the research topics of 'CADASIL: Treatment and Management Options'. Together they form a unique fingerprint.

Cite this